The intricate role of ANG in conjunction with other angiogenic biomarkers in breast cancer‐associated lymphatic anomalies, along with the involvement of additional transcriptional factors in regulating lymphangiogenesis, underscores the importance of identifying key mediators in the ANGs‐VEGFs signaling pathway. This evidence concerns the gene ANG and breast cancer.